Source: centralcharts

Press Release: Connect Biopharma : Connect Biopharma Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a clinical-stage

Read full article »
Connect Biopharma's Competitors | Connect Biopharma's News | Connect Biopharma's Financials
Stay up-to-date with the latest news on Connect Biopharma
Annual Revenue
$25-100M
Employees
25-100
Barry Quart's photo - CEO of Connect Biopharma

CEO

Barry Quart

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on Connect Biopharma